CLINICAL RESEARCH IN EMERGENCY MEDICINE
Professor Daniel Fatovich, Emergency physician and clinical researcher
Royal Perth Hospital Emergency Department &
Head of the Centre for Clinical Research in Emergency Medicine (CCREM)
Harry Perkins Institute of Medical Research &
Clinical Professor, UWA Medical School, Emergency Medicine
University of Western Australia, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | September 2025
Professor Daniel Fatovich is a senior emergency physician and clinical researcher at Royal Perth Hospital Emergency Department (ED), with over 30 years’ experience in the design and conduct of clinical research in Emergency Medicine. He is also Head of the Centre for Clinical Research in Emergency Medicine (CCREM) within the Harry Perkins Institute of Medical Research.
He is Professor of Emergency Medicine, University of Western Australia; Director of Research for East Metropolitan Health Service (EMHS), providing strategic advice and leadership; Board Member of the Royal Perth Hospital Research Foundation; Chair of the EMHS Research Advisory Committee.
Professor Fatovich was an inaugural executive member of the Australasian College for Emergency Medicine (ACEM) Research Committee (2019-2024) and the Clinical Trials Network (2018-2024) and has received over $33m in competitive grant funding.
In 2020 and 2023, he was Ministerial adviser for the passage of the Guardianship and Administration (Medical Research) Act Western Australia. In 2017-18, he was deputy chair of the WA Methamphetamine Taskforce. He is chief investigator for the Emerging Drugs Network of Australia (EDNA), which he describes as the most fabulous project of his career. This is best exemplified by a famous quote from Victor Hugo: there is nothing so powerful as an idea whose time has come. EDNA is a national toxico-surveillance system for detecting illicit, emerging and novel psychoactive substances, in presentations to sentinel Emergency Departments. In 2024, EDNA won a WA Health Excellence Award for Excellence in Research and Innovation, and the 2024 UWA Vice-Chancellor’s Award in Research Impact and Innovation.
Expertscape ranks him in the top 1% globally for expertise in Emergency Medicine. He loves to challenge doctors to think, and to think differently.
Source: Supplied
-
Identification, characterisation and role of leader cells in ovarian cancer progression
Dr. Maree Bilandzic is a molecular cancer biologist dedicated to advancing the understanding and treatment of ovarian cancer (OC). Her research addresses critical gaps in OC treatment by investigating the mechanisms behind metastasis, chemotherapy resistance, and tumour recurrence. By utilising innovative methodologies and disease-representative models, Dr. Bilandzic has pioneered the identification and characterisation of leader cells (LCs)—a unique, stem-like subpopulation within tumours that plays a crucial role in OC progression.
-
Healthcare associated infection prevention
Professor Philip Russo is an internationally regarded expert in healthcare associated infection prevention, and led the recently completed the Australian National Healthcare Associated Infection Point Prevalence Survey, the first in Australia for 34 years. He is also Past President of the Australasian College for Infection Prevention and Control (ACIPC), the peak body for Infection Prevention and Control professionals in the Australasian region.
-
Next generation nanomedicine and radiopharmaceuticals to treat cancer
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
